Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin
US8741839B2 · kind B2 · utility
2Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2010 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Jan 18, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polypeptides comprising variant vascular endothelial growth factor sequences are provided. The polypeptides are useful in cancer imaging, cancer diagnosis, monitoring and treatment as well as treatment of diseases characterized by excessive neovascularization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.